TABLE 4.
Gene | Position | Ref | Alt | AA change | eBLs |
Healthy controls |
P | OR | ||
---|---|---|---|---|---|---|---|---|---|---|
Genotypes | Alt count | Genotypes | Alt count | |||||||
EBNA2 | 37668 | T | C | S485P | 54 | 24 | 36 | 2 | 0.000328 | 0.1 |
EBNA1 | 95773 | A | T | N38Y | 57 | 3 | 36 | 11 | 0.001322 | 6.67213 |
EBNA1 | 95778 | T | G | H39Q | 57 | 3 | 37 | 12 | 0.000538 | 7.16129 |
BcLF1 | 124703 | T | G | K159T | 56 | 1 | 34 | 7 | 0.003178 | 12.7377 |
BcLF1 | 124709 | G | A | A157V | 56 | 1 | 34 | 7 | 0.003092 | 12.7377 |
BARF1 | 165131 | T | C | V29A | 57 | 36 | 36 | 10 | 0.004082 | 0.349462 |
A single nucleotide variant association test results with P < 0.01 after type stratification. The table summarizes the statistically significant single nucleotide variant associations and their effects in the coding regions. Reference (Ref) refers to the genotype based on the consensus of all genomes in the sequencing set, and the variant position denotes the projection to the type 1 reference genome (NC_007605). An association test was performed for every variant position comparing the frequency of reference and alternative (minor allele) bases among eBL patient and healthy control children (Fisher exact test). Empirical P values are based on one million permutations. For the genotypes, genomes with missing data (Ns, lack of coverage) were excluded. Ref, reference allele; Alt, alternative/variant allele; AA, amino acid; OR, odds ratio.